Robert Besser
11 May 2025, 10:46 GMT+10
WASHINGTON, D.C.: This week, U.S. President Donald Trump signed an executive order to speed up the approval of drug manufacturing plants in the United States.
The goal is to encourage more pharmaceutical production within the country.
The order instructs the Food and Drug Administration to expedite the approval process and assist U.S. companies early in the process. It also requests that the FDA improve its tracking of foreign drug ingredients and consider publishing a list of factories that don't comply with regulations.
FDA Commissioner Marty Makary said the agency will begin conducting surprise inspections of drug manufacturing plants overseas to make safety checks more similar to those performed in the U.S.
The order also instructs the Environmental Protection Agency (EPA) to expedite the construction of new pharmaceutical plants.
These steps are part of Mr. Trump's plan to bring drug manufacturing back to the United States. He has recently warned that he might impose tariffs on imported medicines, which have typically been exempt from trade disputes due to health concerns.
Experts say it can take at least five years to build a new drug factory. The White House called this delay a national security risk.
"We will bring our medical supply chains back home and make our medicines and treatments here in America," Trump said.
The Washington Post was the first to report the news.
Last month, the Trump administration initiated investigations into imported drugs and computer chips, stating that the country relies too heavily on foreign production in these areas. Tariffs may be forthcoming, although no specific details have been shared at this time.
If tariffs are imposed, it could be a significant blow to the industry, as the U.S. imports over US$200 billion in prescription drugs.
However, major pharmaceutical companies such as Roche, Novartis, Eli Lilly, and Johnson & Johnson have recently announced significant investments in U.S. manufacturing.
Get a daily dose of Australian Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Australian Herald.
More InformationWASHINGTON, D.C.: This week, U.S. President Donald Trump signed an executive order to speed up the approval of drug manufacturing plants...
AMMAN, Jordan - A United Nations investigative committee has accused Israel of inflicting unimaginable suffering on Palestinians under...
TOKYO, Japan: After nearly three months of complex recovery efforts, the body of a 74-year-old truck driver was found late last week...
WASHINGTON, D.C.: More than 15,000 workers at the U.S. Department of Agriculture (USDA) have accepted offers to leave their jobs in...
TOKYO, Japan: Emperor Emeritus Akihito, 91, will be hospitalized for heart examinations after doctors detected a potential issue during...
MOSCOW, Russia - Russia came to a standstill on Friday as the nation commemorated its victory over Nazi Germany in the second World...
Gurugram (Haryana) [India], May 10 (ANI): Rohit Sharma's retirement from Test cricket on May 7 has drawn reactions from across the...
New Delhi [India], May 10 (ANI): Former India batter Ambati Rayudu penned an emotional note, and requested Virat Kohli not to retire...
New Delhi [India], May 10 (ANI): Bengaluru, Chennai and Hyderabad have been picked out as the venues for the remaining 16 fixtures...
London [UK], May 10 (ANI): Former England skipper Michael Atherton gave his verdict on Indian batter and skipper Rohit Sharma's Test...
New Delhi [India], May 10 (ANI): Indian batting legend Virat Kohli has communicated to the Board of Control for Cricket in India (BCCI)...
Los Angeles [US], May 9 (ANI): Golden Globe nominee Joel Edgerton and Golden Globe winner Toni Collette will be seen headlining Australian...